These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30683601)

  • 1. Spleen in hepatocellular carcinoma: More complexity and importance than we knew.
    Wei W; Li L; Kong G; Zheng Z; Ji F; Li Z
    J Hepatol; 2019 Apr; 70(4):805-806. PubMed ID: 30683601
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to correspondence concerning: "Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection".
    Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
    J Hepatol; 2019 Apr; 70(4):809-810. PubMed ID: 30661766
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting post-resection recurrence of hepatocellular carcinoma: Spleen stiffness vs. ALBI grade.
    Huo TI; Liu PH; Hsu CY
    J Hepatol; 2019 Apr; 70(4):808. PubMed ID: 30678994
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection: A comment for moving forward.
    Xiang X; Wang Y; Mo DC; Wang SQ; Xun XD; Hu SH; Cheng Q; Li Z; Zhu JY
    J Hepatol; 2019 Apr; 70(4):806-807. PubMed ID: 30685124
    [No Abstract]   [Full Text] [Related]  

  • 5. Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report.
    Gringeri E; Boetto R; Bassi D; D'Amico FE; Polacco M; Romano M; Neri D; Feltracco P; Zanus G; Cillo U
    Prog Transplant; 2014 Jun; 24(2):142-5. PubMed ID: 24919730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis.
    Shen SL; Wang W; Fu SJ; Peng BG
    Ann Surg Oncol; 2017 Dec; 24(Suppl 3):653-654. PubMed ID: 29124489
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of hepatocellular carcinoma of the liver with diffuse metastases in the spleen].
    BEHRENS H
    Zentralbl Allg Pathol; 1951 Jan; 87(1):18-23. PubMed ID: 14828929
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of hepatocellular carcinoma after liver retransplantation.
    Klompmaker IJ; de Bruijn KM; Gouw AH; Bams JI; Slooff MJ
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1445. PubMed ID: 2837306
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect.
    Mancuso A; Maringhini A
    Am J Surg; 2018 Aug; 216(2):389-390. PubMed ID: 28454660
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence of hepatocellular carcinoma.
    Sherman M
    N Engl J Med; 2008 Nov; 359(19):2045-7. PubMed ID: 18923166
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to: Considerations on "Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation".
    Kim SH
    Eur J Surg Oncol; 2019 Apr; 45(4):717-718. PubMed ID: 30803907
    [No Abstract]   [Full Text] [Related]  

  • 12. "Local recurrence" is not equal to "Local dissemination" after resection for hepatocellular carcinoma.
    Marubashi S; Sakon M
    J Hepatol; 2016 Nov; 65(5):1061. PubMed ID: 27453464
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Schwartz M; Konstadoulakis M; Roayaie S
    Liver Transpl; 2005 May; 11(5):494-6. PubMed ID: 15838915
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to: ""Local recurrence" is not equal to "Local dissemination" after resection for hepatocellular carcinoma".
    Shindoh J; Hasegawa K; Matsuyama Y; Makuuchi M; Kokudo N
    J Hepatol; 2016 Nov; 65(5):1062-1063. PubMed ID: 27448705
    [No Abstract]   [Full Text] [Related]  

  • 15. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
    Izumi N
    J Gastroenterol; 2003; 38(9):918-20. PubMed ID: 14564643
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-acting antivirals and recurrence of hepatocellular carcinoma.
    Marrero JA; Singal AG
    Liver Transpl; 2017 Sep; 23(9):1099-1100. PubMed ID: 28722785
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report.
    Nelson AC; Jessurun J; Peterson RK; Pambuccian SE
    Liver Transpl; 2012 May; 18(5):612-4. PubMed ID: 22344889
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver transplantation for hepatocellular carcinoma. Mid-term results].
    Gugenheim J; Crafa F; Fabiani P; Saint-Paul MC; Goubaux B; Ouzan D; Mouiel J
    Presse Med; 1992 Nov; 21(39):1846-8. PubMed ID: 1337383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.